Intra-arterial chemoradiotherapy for head and neck cancer-Reference-Cited by-同舟云学术

Intra-arterial chemoradiotherapy for head and neck cancer

Published:2015-10-20 Issue:1 Volume:46 Page:4-12
ISSN:0368-2811
Container-title:Japanese Journal of Clinical Oncology
language:en
Short-container-title:Jpn. J. Clin. Oncol.

Author:

Homma Akihiro,Onimaru Rikiya,Matsuura Kazuto,Robbins K. Thomas,Fujii Masato

Funder

Practical Research for Innovative Cancer Control

Japan Agency for Medical Research and development, AMED

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://academic.oup.com/jjco/article-pdf/46/1/4/2391236/hyv151.pdf

Reference79 articles.

1. GLOBAN. 2012. http://globocan.iarc.fr/Default.aspx (18 August 2015, date last accessed).

2. NCCN Clinical Practice Guidelines in Oncology Head and Neck Cancers V.1.2015. http://www.nccn.org/professionals/physician_gls/pdf/head-and-neck.pdf (18 August 2015, date last accessed).

3. Head and Neck Cancer

4. A Novel Organ Preservation Protocol for Advanced Carcinoma of the Larynx and Pharynx

5. Intra-arterial cisplatin and FUDR in advanced malignancies confined to the head and neck;Forastiere;J Clin Oncol,1987

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Post-treatment magnetic resonance imaging predicts outcomes of maxillary sinus cancer treatment using super-selective intra-arterial infusion of high-dose cisplatin with concomitant radiotherapy (RADPLAT);Auris Nasus Larynx;2024-08

2. Prospects of Synergy: Local Interventions and CAR T Cell Therapy in Solid Tumors;BioDrugs;2024-07-30

3. Intra-arterial chemoradiotherapy for oral cancer: Superiority of intensity-modulated radiation therapy over three-dimensional conformal radiation therapy;Journal of Stomatology, Oral and Maxillofacial Surgery;2024-07

4. Complete response of glottic cancer to intra-arterial infusion chemotherapy combined with radiotherapy: A report of 4 cases;Radiology Case Reports;2023-12

5. Antibiotics May Interfere with Nivolumab Efficacy in Patients with Head and Neck Squamous Cell Carcinoma;Oncology;2023-09-14